All lobbying filings

MARSHALL & POPP, LLC

Lobbying for ELI LILLY AND COMPANY · Biopharmaceutical manufacturer.

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · Indiana · House · Senate · $60,000.00 income · posted Apr 17, 2026

Official filing document

Lobbying activity 2

Medicare/Medicaid

Issues related to treatments for Alzheimers therapeutics.

Pharmacy

Issues related to prescription drug value, including implementation of the Inflation Reduction Act (PL 117-169), and implementation of Executive Order 14273, Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients. Issues related to FDA regulation of pharmaceuticals. Issues related to the 340B program.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.